Patient preferences for pharmacological treatments for obesity: The VOICE study.
Saved in:
| Title: | Patient preferences for pharmacological treatments for obesity: The VOICE study. |
|---|---|
| Authors: | Houle C; Eli Lilly and Company, 893 S, Delaware Street, Indianapolis, IN, 46285, USA., Gelhorn H; Thermo Fisher Scientific, 163 3rd Avenue, Waltham, MA, 02451, USA., Cutts K; Thermo Fisher Scientific, 163 3rd Avenue, Waltham, MA, 02451, USA., Samuelson A; Thermo Fisher Scientific, 163 3rd Avenue, Waltham, MA, 02451, USA., Xavier N; Eli Lilly and Company, 893 S, Delaware Street, Indianapolis, IN, 46285, USA. |
| Source: | Obesity pillars [Obes Pillars] 2026 May 25; Vol. 19, pp. 100278. Date of Electronic Publication: 2026 May 25 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918697364706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-3681 (Electronic) Linking ISSN: 26673681 NLM ISO Abbreviation: Obes Pillars Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42245198 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Patient preferences for pharmacological treatments for obesity: The VOICE study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Houle+C%22">Houle C</searchLink>; Eli Lilly and Company, 893 S, Delaware Street, Indianapolis, IN, 46285, USA.<br /><searchLink fieldCode="AU" term="%22Gelhorn+H%22">Gelhorn H</searchLink>; Thermo Fisher Scientific, 163 3rd Avenue, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Cutts+K%22">Cutts K</searchLink>; Thermo Fisher Scientific, 163 3rd Avenue, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Samuelson+A%22">Samuelson A</searchLink>; Thermo Fisher Scientific, 163 3rd Avenue, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Xavier+N%22">Xavier N</searchLink>; Eli Lilly and Company, 893 S, Delaware Street, Indianapolis, IN, 46285, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918697364706676%22">Obesity pillars</searchLink> [Obes Pillars] 2026 May 25; Vol. 19, pp. 100278. <i>Date of Electronic Publication: </i>2026 May 25 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918697364706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2667-3681 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226673681%22">26673681 </searchLink><i>NLM ISO Abbreviation: </i>Obes Pillars <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42245198 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.obpill.2026.100278 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100278 Titles: – TitleFull: Patient preferences for pharmacological treatments for obesity: The VOICE study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Houle C – PersonEntity: Name: NameFull: Gelhorn H – PersonEntity: Name: NameFull: Cutts K – PersonEntity: Name: NameFull: Samuelson A – PersonEntity: Name: NameFull: Xavier N IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 05 Text: 2026 May 25 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2667-3681 Numbering: – Type: volume Value: 19 Titles: – TitleFull: Obesity pillars Type: main |
| ResultId | 1 |